Standardized extract according to the product.
Adaptogen signal, with limited evidence.
View the study (RCT) →May improve some liver markers; preliminary data.
⏱ 3 min read
Schisandra, also known as wu wei zi (the "five-flavor berry" in Chinese, because it simultaneously combines the five basic taste notes), is Schisandra chinensis, a climbing plant from East Asia whose dried fruits have been used in traditional Chinese medicine for more than 2,000 years as a liver tonic, adaptogen, and restorer of vital energy; it is one of the classic adaptogens in the Chinese and Soviet phytotherapy repertoire, along with ginseng, eleuthero, rhodiola, and astragalus, a heterogeneous category of plants credited with the ability to increase the body's nonspecific resistance to multiple types of physical, mental, and chemical stress.
The identified active principles are the lignans of the schisandrin group (especially schisandrin A, B, and C, gomisin, and others), a chemical family with documented activity on the hepatic cytochrome P450 system, on oxidative stress receptors, and on neuroendocrine pathways related to the cortisol response; this multiplicity of mechanisms explains the broad clinical profile and the promising experimental data in hepatoprotection, neuroprotection, and modulation of physical and cognitive performance under stress.
The indication with the most evidence is hepatoprotection: schisandra has shown protective effects against chemical hepatotoxicity (acetaminophen, alcohol, environmental pollutants) in animal models and in small clinical studies of patients with chronic viral or toxic hepatitis; several Chinese trials have documented significant reductions in transaminases (ALT, AST) and improvements in liver symptoms with standardized extract over weeks to months, with modest but clinically consistent effect sizes.
The mechanism is multiple: induction of hepatic phase II enzymes (glutathione S-transferase, quinone reductase), stimulation of hepatocyte regeneration, modulation of inflammatory pathways, and a direct antioxidant effect; in China, schisandra is part of several traditional formulations with an official indication as an adjunct in chronic liver disease, a practice backed by decades of use but with clinical data that are predominantly local and require validation in Western cohorts.
As an adaptogen, schisandra has shown effects on fatigue induced by chronic stress, on physical and mental performance under demanding conditions, and on modulation of salivary cortisol; Soviet studies from the 1950s and 1960s documented improvements in endurance and recovery in athletes, military personnel, and workers exposed to prolonged stress, data consistent with the effects observed in more recent studies using modern methodology but limited by small sample size and heterogeneity of protocols.
In cognition, several small trials have shown improvements in processing speed, sustained attention, and working memory with doses of 500-1,000 milligrams daily of standardized extract over weeks to months; the effects are modest but replicable, especially in adults with chronic stress or mental fatigue, an indication consistent with the general adaptogenic profile.
In athletes, schisandra supplementation has shown improvements in recovery markers (creatine kinase, testosterone/cortisol ratio) and in endurance performance after intense exertion, with modest but consistent effect sizes; the data are less abundant than for rhodiola or ashwagandha but point in a similar direction.
The doses studied range from 500 to 2,000 milligrams daily of dry fruit extract (standardized to lignans, ideally with a declared schisandrin A content or totalsis), divided into one or two doses with or without food; the effects on stress and energy appear gradually, typically from the second or third week, and are maintained as long as use continues; traditional Chinese practice uses the dried fruit as a decoction at higher equivalent doses.
Generally well tolerated, with documented millennia-long use; the adverse effects described are rare and mild (digestive discomfort, headache, occasionally insomnia if taken very late or at high doses, mild general activation); the most relevant pharmacokinetic consideration is the induction of hepatic cytochrome P450 enzymes (especially CYP3A4), which can speed up metabolism and reduce the concentrations of drugs metabolized by this pathway (some immunosuppressants, antiretrovirals, oral anticoagulants, contraceptives, statins); people with epilepsy or elevated intracranial pressure should avoid it because of preliminary data on neurological modulation; it is contraindicated in pregnancy because of a described uterotonic effect; in breastfeeding, data are limited and avoidance is recommended; people with active peptic ulcer or severe gastroesophageal reflux should use caution because of an occasional gastric acidifying effect.
Information, not medical advice. Scientific evidence reflects the quality of the studies.